相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling
Rui Su et al.
CELL (2018)
Fatty acid-binding protein FABP4 mechanistically links obesity with aggressive AML by enhancing aberrant DNA methylation in AML cells
F. Yan et al.
LEUKEMIA (2017)
Reversible methylation of m6Am in the 5′ cap controls mRNA stability
Jan Mauer et al.
NATURE (2017)
m6A Facilitates eIF4F-Independent mRNA Translation
Ryan A. Coots et al.
MOLECULAR CELL (2017)
m6A-dependent maternal mRNA clearance facilitates zebrafish maternal-to-zygotic transition
Boxuan Simen Zhao et al.
NATURE (2017)
N6-methyladenosine demethylase FTO targets pre-mRNAs and regulates alternative splicing and 3'-end processing
Marek Bartosovic et al.
NUCLEIC ACIDS RESEARCH (2017)
A regulatory circuit composed of DNA methyltransferases and receptor tyrosine kinases controls lung cancer cell aggressiveness
F. Yan et al.
ONCOGENE (2017)
Inactivation of Receptor Tyrosine Kinases Reverts Aberrant DNA Methylation in Acute Myeloid Leukemia
Na Shen et al.
CLINICAL CANCER RESEARCH (2017)
Dynamic RNA Modifications in Gene Expression Regulation
Ian A. Roundtree et al.
CELL (2017)
FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase
Zejuan Li et al.
CANCER CELL (2017)
A novel algorithm for calling mRNA m6A peaks by modeling biological variances in MeRIP-seq data
Xiaodong Cui et al.
BIOINFORMATICS (2016)
Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy
Michael P. Smith et al.
CANCER CELL (2016)
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
Aaron N. Hata et al.
NATURE MEDICINE (2016)
MetaDiff: differential isoform expression analysis using random-effects meta-regression
Cheng Jia et al.
BMC BIOINFORMATICS (2015)
N6-methyladenosine Modulates Messenger RNA Translation Efficiency
Xiao Wang et al.
CELL (2015)
m6A RNA Methylation Is Regulated by MicroRNAs and Promotes Reprogramming to Pluripotency
Tong Chen et al.
CELL STEM CELL (2015)
A majority of m6A residues are in the last exons, allowing the potential for 3′ UTR regulation
Shengdong Ke et al.
GENES & DEVELOPMENT (2015)
AML1/ETO cooperates with HIF1α to promote leukemogenesis through DNMT3α transactivation
X. N. Gao et al.
LEUKEMIA (2015)
Dynamic m6A mRNA methylation directs translational control of heat shock response
Jun Zhou et al.
NATURE (2015)
m6A mRNA methylation facilitates resolution of naive pluripotency toward differentiation
Shay Geula et al.
SCIENCE (2015)
Meclofenamic acid selectively inhibits FTO demethylation of m(6)A over ALKBH5
Yue Huang et al.
NUCLEIC ACIDS RESEARCH (2015)
Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells
Ho-June Lee et al.
CANCER CELL (2014)
FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis
Xu Zhao et al.
CELL RESEARCH (2014)
m6A RNA Modification Controls Cell Fate Transition in Mammalian Embryonic Stem Cells
Pedro J. Batista et al.
CELL STEM CELL (2014)
N6-methyladenosine-dependent regulation of messenger RNA stability
Xiao Wang et al.
NATURE (2014)
A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation
Jianzhao Liu et al.
NATURE CHEMICAL BIOLOGY (2014)
Structural basis for selective binding of m6A RNA by the YTHDC1 YTH domain
Chao Xu et al.
NATURE CHEMICAL BIOLOGY (2014)
An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia
Birgit Knoechel et al.
NATURE GENETICS (2014)
Gene expression regulation mediated through reversible m6A RNA methylation
Ye Fu et al.
NATURE REVIEWS GENETICS (2014)
The dynamic epitranscriptome: N6-methyladenosine and gene expression control
Kate D. Meyer et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Perturbation of m6A Writers Reveals Two Distinct Classes of mRNA Methylation at Internal and 5′ Sites
Schraga Schwartz et al.
CELL REPORTS (2014)
High-Resolution Mapping Reveals a Conserved, Widespread, Dynamic mRNA Methylation Program in Yeast Meiosis
Schraga Schwartz et al.
CELL (2013)
ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility
Guanqun Zheng et al.
MOLECULAR CELL (2013)
The fat mass and obesity associated gene (Fto) regulates activity of the dopaminergic midbrain circuitry
Martin E. Hess et al.
NATURE NEUROSCIENCE (2013)
Transcriptome-wide mapping of N6-methyladenosine by m6A-seq based on immunocapturing and massively parallel sequencing
Dan Dominissini et al.
NATURE PROTOCOLS (2013)
Inhibition of PI3K/mTOR Overcomes Nilotinib Resistance in BCR-ABL1 Positive Leukemia Cells through Translational Down-Regulation of MDM2
Jie Ding et al.
PLOS ONE (2013)
Role for the obesity-related FTO gene in the cellular sensing of amino acids
Pawan Gulati et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Brief report Poor response to second-line kinase inhibitors in chronic myeloid leukemia patients with multiple low-level mutations, irrespective of their resistance profile
Wendy T. Parker et al.
BLOOD (2012)
Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop Codons
Kate D. Meyer et al.
CELL (2012)
Development of Cell-Active N6-Methyladenosine RNA Demethylase FTO Inhibitor
Baoen Chen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Heterodimeric JAK-STAT activation as a mechanism of persistence to JAK2 inhibitor therapy
Priya Koppikar et al.
NATURE (2012)
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq
Dan Dominissini et al.
NATURE (2012)
Nilotinib and MEK Inhibitors Induce Synthetic Lethality through Paradoxical Activation of RAF in Drug-Resistant Chronic Myeloid Leukemia
Leisl M. Packer et al.
CANCER CELL (2011)
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition
Cihangir Duy et al.
NATURE (2011)
N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
Guifang Jia et al.
NATURE CHEMICAL BIOLOGY (2011)
Mechanisms of AXL overexpression and function in Imatinibresistant chronic myeloid leukemia cells
Maeva Dufies et al.
ONCOTARGET (2011)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities
Sven Heinz et al.
MOLECULAR CELL (2010)
AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
Thomas O'Hare et al.
CANCER CELL (2009)
SUnSET, a nonradioactive method to monitor protein synthesis
Enrico K. Schmidt et al.
NATURE METHODS (2009)
Prognostic relevance of FLT3-TKD mutations in AML:: the combination matters -: an analysis of 3082 patients
Ulrike Bacher et al.
BLOOD (2008)
Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases
TA Carter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl
E Weisberg et al.
CANCER CELL (2005)
Imatinib mesylate resistance through BCR-ABL independence in chronic myelogenous leukemia
NJ Donato et al.
CANCER RESEARCH (2004)
A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2
Y Dai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
分享论文
